BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6966335)

  • 1. In vitro cytotoxicity against Marek's disease lymphoblastoid cell lines after enzymatic removal of Marek's disease tumor-associated surface antigen.
    Schat KA; Murthy KK
    J Virol; 1980 Apr; 34(1):130-5. PubMed ID: 6966335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demonstration of Marek's disease tumor-associated surface antigen in chickens infected with nononcogenic Marek's disease virus and herpesvirus of turkeys.
    Schat KA; Calnek BW
    J Natl Cancer Inst; 1978 Sep; 61(3):855-7. PubMed ID: 211242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Marek's disease tumor-associated surface antigen on MDCC-MSB1-clo.18 cells.
    Horie M; Ohashi K; Kodama H; Mikami T
    Int J Cancer; 1991 Jan; 47(2):238-43. PubMed ID: 1703127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A monoclonal antibody reactive with Marek's disease tumor-associated surface antigen.
    Lee LF; Liu X; Sharma JM; Nazerian K; Bacon LD
    J Immunol; 1983 Feb; 130(2):1007-11. PubMed ID: 6294177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of cell-mediated immunity to Marek's disease tumor cells in chickens inoculated with Marek's disease vaccines.
    Sharma JM; Witter RL; Coulson BD
    J Natl Cancer Inst; 1978 Nov; 61(5):1273-80. PubMed ID: 213610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody directed against Marek's disease-associated tumor surface antigen can be eluted from Marek's disease tumor cells.
    Pradhan HK; Mohanty GC; Lee WY; Patnaik B
    Vet Immunol Immunopathol; 1991 Sep; 29(3-4):229-38. PubMed ID: 1659032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-idiotype antibodies to Marek's disease-associated tumour surface antigen in protection against Marek's disease.
    Dandapat S; Pradhan HK; Mohanty GC
    Vet Immunol Immunopathol; 1994 Apr; 40(4):353-66. PubMed ID: 8042285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of a putative tumor-associated surface antigen on normal versus Marek's disease virus-transformed lymphocytes.
    McColl KA; Calnek BW; Harris WV; Schat KA; Lee LF
    J Natl Cancer Inst; 1987 Nov; 79(5):991-1000. PubMed ID: 3479647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-mediated cytotoxic response to cells bearing Marek's disease tumor-associated surface antigen in chickens infected with Marek's disease virus.
    Sharma JM; Coulson BD
    J Natl Cancer Inst; 1977 Jun; 58(6):1647-51. PubMed ID: 68120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of Marek's disease: early appearance of Marek's disease tumor-associated surface antigen in infected chickens.
    Murthy KK; Calnek BW
    J Natl Cancer Inst; 1978 Sep; 61(3):849-54. PubMed ID: 357748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nature of genetic resistance to Marek's disease in chickens.
    Lee LF; Powell PC; Rennie M; Ross LJ; Payne LN
    J Natl Cancer Inst; 1981 Apr; 66(4):789-96. PubMed ID: 6262555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-mediated immunity to tumor antigen in Marek's disease: susceptibility of effector cells to antithymocyte serum and enhancement of cytotoxic activity by Vibrio cholerae neuraminidase.
    Sharma JM
    Infect Immun; 1977 Oct; 18(1):46-51. PubMed ID: 302827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and characterization of monoclonal antibodies to Marek's disease tumor-associated surface antigen.
    Liu XF; Lee LF
    Infect Immun; 1983 Aug; 41(2):851-4. PubMed ID: 6874076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of a Marek's disease tumor-associated surface antigen (MATSA) on six cell lines derived from Marek's disease lymphomas.
    Matsuda H; Ikuta K; Miyamoto H; Kato S
    Biken J; 1976 Sep; 19(3):119-23. PubMed ID: 797387
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibody-induced redistribution of Marek's disease tumor-associated surface antigen (MATSA) on lymphoblastoid line (MSB-1) cells derived from Marek's disease lymphoma.
    Matsuda H; Ikuta K; Miyamoto H; Kato S
    Biken J; 1977 Mar; 20(1):35-7. PubMed ID: 328007
    [No Abstract]   [Full Text] [Related]  

  • 16. Properties of Marek's disease tumor-associated surface antigen of MSB-1 cells.
    Suzuki K; Mikami T; Onuma M; Kodama H; Izawa H
    Zentralbl Veterinarmed B; 1981; 28(9-10):684-92. PubMed ID: 7342579
    [No Abstract]   [Full Text] [Related]  

  • 17. Marek's disease tumor-associated surface antigen (MATSA) in resistant versus susceptible chickens.
    Murthy KK; Calnek BW
    Avian Dis; 1979; 23(4):831-7. PubMed ID: 232656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of monoclonal antibodies reactive with Marek's disease tumor-associated surface antigen (MATSA).
    Ikuta K; Ueda S; Kato S; Ono K; Osafune S; Yoshida I; Konobe T; Naito I; Naito M; Hirai K
    Biken J; 1984 Dec; 27(4):183-8. PubMed ID: 6399439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nonproducer T lymphoblastoid cell line from Marek's disease transplantable tumor (JMV).
    Nazerian K; Stephens EA; Sharma JM; Lee LF; Gailitis M; Witter RL
    Avian Dis; 1977; 21(1):69-76. PubMed ID: 190995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo growth inhibition of transplantable Marek's disease lymphomas by monoclonal antibodies against surface antigens on Marek's disease lymphoblastoid cell line.
    Higashihara T; Tamura H; Mikami T
    Nihon Juigaku Zasshi; 1990 Dec; 52(6):1265-8. PubMed ID: 2149576
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.